Heidelberg Financial Statements From 2010 to 2025
| HPHA Stock | EUR 2.42 0.00 0.00% |
Check Heidelberg Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Heidelberg Pharma's main balance sheet or income statement drivers, such as , as well as many indicators such as . Heidelberg financial statements analysis is a perfect complement when working with Heidelberg Pharma Valuation or Volatility modules.
Heidelberg |
Heidelberg Pharma AG Company Price To Sales Analysis
Heidelberg Pharma's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Current Heidelberg Pharma Price To Sales | 12.57 X |
Most of Heidelberg Pharma's fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Heidelberg Pharma AG is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
| Competition |
Based on the latest financial disclosure, Heidelberg Pharma AG has a Price To Sales of 12.5655 times. This is much higher than that of the sector and significantly higher than that of the Price To Sales industry. The price to sales for all Germany stocks is notably lower than that of the firm.
Heidelberg Pharma Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Heidelberg Pharma's current stock value. Our valuation model uses many indicators to compare Heidelberg Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Heidelberg Pharma competition to find correlations between indicators driving Heidelberg Pharma's intrinsic value. More Info.Heidelberg Pharma AG is rated below average in current valuation category among its peers. It is rated below average in price to book category among its peers . The ratio of Current Valuation to Price To Book for Heidelberg Pharma AG is about 7,648,659 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Heidelberg Pharma's earnings, one of the primary drivers of an investment's value.About Heidelberg Pharma Financial Statements
Heidelberg Pharma shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Heidelberg Pharma investors may analyze each financial statement separately, they are all interrelated. The changes in Heidelberg Pharma's assets and liabilities, for example, are also reflected in the revenues and expenses on on Heidelberg Pharma's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Heidelberg Stock Analysis
When running Heidelberg Pharma's price analysis, check to measure Heidelberg Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heidelberg Pharma is operating at the current time. Most of Heidelberg Pharma's value examination focuses on studying past and present price action to predict the probability of Heidelberg Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heidelberg Pharma's price. Additionally, you may evaluate how the addition of Heidelberg Pharma to your portfolios can decrease your overall portfolio volatility.